Bigfoot Biomedical lands $45M as it readies first diabetes product
The money will help the company launch its first insulin-management product by the end of this year, which is likely to face stiff competition from larger rivals.
Bigfoot brings in $55M Series B to propel integrated diabetes platform
The California startup is attempting to create a closed-loop and integrated diabetes platform that attracted Abbott, whic has been a partner since July to invest.
The Power of One: Redefining Healthcare with an AI-Driven Unified Platform
In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation.
Breakout Labs backs antibacterials, genomics and biosensor tattoos
From California to Boston to NYC, four more life science startups have been accepted into the Thiel Foundation's Breakout Labs, a philanthropic incubator for seed-stage companies.